<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Circulating myeloid progenitors were assayed in 172 <z:mpath ids='MPATH_458'>normal</z:mpath> subjects and 147 patients with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>Patients whose cultures had colony/cluster ratios (CCR) less than 0.3 had significantly shorter survival periods than comparable patients with CCR greater than 0.3 </plain></SENT>
<SENT sid="2" pm="."><plain>A second prognostic indicator, which complemented CCR, was identified in patients with less than 5% blasts </plain></SENT>
<SENT sid="3" pm="."><plain>Median survival was significantly reduced in patients with greater than 15 clusters/ml blood despite colony and cluster numbers being predominantly within the <z:mpath ids='MPATH_458'>normal</z:mpath> range </plain></SENT>
<SENT sid="4" pm="."><plain>Characteristic differences were found in three FAB groups large enough to allow statistical analysis </plain></SENT>
<SENT sid="5" pm="."><plain>Survival amongst patients with refractory <z:hpo ids='HP_0001903'>anaemia</z:hpo> with excess of blasts (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>) was related to CCR and was independent of cluster number </plain></SENT>
<SENT sid="6" pm="."><plain>Amongst sideroblastic patients (SA) survival related only to cluster number </plain></SENT>
<SENT sid="7" pm="."><plain>Refractory <z:hpo ids='HP_0001903'>anaemia</z:hpo> (RA) patients included individuals in both high-risk groups with only three patients out of 64 showing both features </plain></SENT>
<SENT sid="8" pm="."><plain>Amongst <z:hpo ids='HP_0000001'>all</z:hpo> the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients, those with CCR greater than 0.3 and less than 15 clusters/ml blood formed a low-risk group (n = 60) with a relatively good prognosis of whom 85% survived the study period (median duration 938 d) including 94% of those in this group with less than 5% marrow blast cells </plain></SENT>
</text></document>